Profile

Michael V. Rocco, M.D.Wake Forest Baptist Health

Doctor Rating

4.6 out of 5

58 Ratings
1 Comments

Michael V. Rocco, M.D.

Professor,

Clinical Specialties

Renal Failure, Nephrolithiasis, Clinical Nephrology, Dialysis, Hypertension, Nephrology, Kidney Disease

Contact Information

New Patient Appointments: 336-716-WAKE
Returning Patient Appointments: 336-716-2097
Department: 336-716-4650

Insurance Accepted »

Education & Training

  • B.S., Seton Hall University , 1981
  • M.D., Vanderbilt University School of Medicine , 1985
  • M.S., WFU School of Medicine , 1994
  • Residency, Vanderbilt U Affil Hosps, 1988
  • Fellowship, Hosp Of The Univ Penn, 1991

Board Certifications

  • American Board of Internal Medicine, Internal Medicine, American Board of Internal Medicine
  • American Board of Internal Medicine, Internal Medicine - Nephrology

Memberships

  • Int'L Society Of Nephrology
  • Nat'L Kidney Foundation
  • Am Soc Of Nephrology

NPI Number

  • 1437134525
Michael V. Rocco, M.D.

Doctor Rating

4.6 out of 5

58 Ratings
1 Comments

Michael V. Rocco, M.D.

Professor, Nephrology
Public Health Sciences

Research Interests

cancer/oncogenesis, cardiac function, diabetes, drugs/therapeutic agents pharm

Contact Information

Academic: 336-716-2097 | Department: 336-716-4650

Recent Publications

Divers J, Palmer ND, Lu L, Langefeld CD, Rocco MV, Hicks PJ, Murea M, Ma L, Bowden DW, Freedman BI. Gene-gene interactions in APOL1-associated nephropathy. Nephrol Dial Transplant. 2014;29(3):587-594.

Hall ME, Rocco MV, Morgan TM, Hamilton CA, Edwards MS, Jordan JH, Hurie JB, Hundley WG. Chronic diuretic therapy attenuates renal BOLD magnetic resonance response to an acute furosemide stimulus. J Cardiovasc Magn Reson. 2014;16(1):17.

Turner KR, Fisher EC, Hade EM, Houle TT, Rocco MV. The role of perioperative sodium bicarbonate infusion affecting renal function after cardiothoracic surgery. Front Pharmacol. 2014;5():127.

Rocco M, Daugirdas J, Greene T, Lockridge R, Chan C, Pierratos A, Lindsay R, Larive B, Chertow G, Beck G, Eggers P, Kliger A, Laville M, Dorval M, Fort Ros J, Fay R, Cridlig J, Nortier JL, Juillard L, Debska-Slizien A, Fernandez Lorente L, Thibaudin D,. New dialysis techniques [abstract]. Nephrol Dial Transplant. 2014;29(Suppl 3):.

Ambrosius WT, Sink KM, Foy CG, Berlowitz DR, Cheung AK, Cushman WC, Fine LJ, Goff DC Jr, Johnson KC, Killeen AA, Lewis CE, Oparil S, Reboussin DM, Rocco MV, Williamson JD, Wright JT Jr, Whelton PK. The design and rationale of a multicenter clinical trial comparing two strategies for control of systolic blood pressure: the Systolic Blood Pressure Intervention Trial (SPRINT). Clin Trials. 2014;11(5):532-546.

Langefeld CD, Divers J, Pajewski NM, Hawfield AT, Reboussin DM, Bild DE, Kaysen GA, Kimmel PL, Raj DS, Ricardo AC, Wright JT Jr, Sedor JR, Rocco MV, Freedman BI. Apolipoprotein L1 gene variants associate with prevalent kidney but not prevalent cardiovascular disease in the Systolic Blood Pressure Intervention Trial. Kidney Int. 2014;():.

Chan CT, Covic A, Craig JC, Davenport A, Kasiske BL, Kuhlmann MK, Levin NW, Li PK, Locatelli F, Rocco MV, Wheeler DC. Novel techniques and innovation in blood purification: a clinical update from Kidney Disease: Improving Global Outcomes. Kidney Int. 2013;83(3):359-371.

Suri RS, Larive B, Sherer S, Eggers P, Gassman J, James SH, Lindsay RM, Lockridge RS, Ornt DB, Rocco MV, Ting GO, Kliger AS. Risk of vascular access complications with frequent hemodialysis. J Am Soc Nephrol. 2013;24(3):498-505.

Rocco MV. Does more frequent hemodialysis provide dietary freedom?. J Ren Nutr. 2013;23(3):259-262.

Daugirdas JT, Greene T, Rocco MV, Kaysen GA, Depner TA, Levin NW, Chertow GM, Ornt DB, Raimann JG, Larive B, Kliger AS. Effect of frequent hemodialysis on residual kidney function. Kidney Int. 2013;83(5):949-958.

Reeves-Daniel AM, Farney AC, Fletcher AJ, Assimos D, Westcott C, Rogers J, Stratta RJ, Rocco MV, Freedman BI. Ethnicity, medical insurance, and living kidney donation. Clin Transplant. 2013;27(4):E498-E503.

Divers J, Palmer ND, Lu L, Langefeld CD, Rocco MV, Hicks PJ, Murea M, Ma L, Bowden DW, Freedman BI. Gene-gene interactions in APOL1-associated nephropathy [abstract]. J Am Soc Nephrol. 2013;24(Abstract Suppl):67A.

Greene T, Daugirdas JT, Chertow GM, Levin NW, Rocco MV, Beck GJ, Kliger AS. Bayesian interpretation of the estimated treatment effects on mortality in the daily and nocturnal Frequent Hemodialysis Trials (FHN) [abstract]. J Am Soc Nephrol. 2013;24(Abstract Suppl):439A.

Daugirdas JT, Larive B, Depner TA, Pierratos A, Greene T, Lockridge RS, Ayus JC, Rocco MV, Chertow GM, Leypoldt JK, Akonur A, Miller BW. The magnitude of phosphorus mobilization during dialysis in the Frequent Hemodialysis Network (FHN) daily trial was patient-specific [abstract]. J Am Soc Nephrol. 2013;24(Abstract Suppl):439A.

Chertow GM, Levin NW, Back GJ, Eggers PW, Greene T, Larive B, Rocco MV, Kliger AS. Effects of randomization to frequent in-center hemodialysis on long-term mortality: Frequent Hemodialysis Daily Trial [abstract]. J Am Soc Nephrol. 2013;24(Abstract Suppl):442A.

Beck GJ, Chertow GM, Eggers PW, Greene T, Larive B, Levin NW, Rajagopalan S, Rocco MV, Sanz J, Tran T, Kramer C, Kliger AS. Influence of methodology on left ventricular mass measurement by cardiac magnetic resonance in the Frequent Hemodialysis Network (FHN) Nocturnal Trial [abstract]. J Am Soc Nephrol. 2013;24(Abstract Suppl):726A.

Rocco MV, Daugirdas JT, Greene T, Lockridge RS, Pierratos A, Larive B, Beck GJ, Kliger AS. Effects of randomization to frequent nocturnal hemodialysis on long-term mortality: Frequent Hemodialysis Network Nocturnal Trial [abstract]. J Am Soc Nephrol. 2013;24(Abstract Suppl):443A.

Estrella MM, Jaar BG, Cavanaugh KL, Fox CH, Perazella MA, Soman SS, Howell E, Rocco MV, Choi MJ. Perceptions and use of the national kidney foundation KDOQI guidelines: a survey of U.S. renal healthcare providers. BMC Nephrol. 2013;14(1):230.

Divers J, Nunez M, High KP, Murea M, Rocco MV, Ma L, Bowden DW, Hicks PJ, Spainhour M, Ornelles DA, Kleiboeker SB, Duncan K, Langefeld CD, Turner J, Freedman BI. JC polyoma virus interacts with APOL1 in African Americans with nondiabetic nephropathy. Kidney Int. 2013;84(6):1207-1213.

Su CT, Yabes J, Pike F, Weiner DE, Beddhu S, Burrowes JD, Rocco MV, Unruh ML. Changes in anthropometry and mortality in maintenance hemodialysis patients in the HEMO Study. Am J Kidney Dis. 2013;62(6):1141-1150.

Chan CT, Greene T, Chertow GM, Kliger AS, Stokes JB, Beck GJ, Daugirdas JT, Kotanko P, Larive B, Levin NW, Mehta RL, Rocco M, Sanz J, Yang PC, Rajagopalan S. Effects of frequent hemodialysis on ventricular volumes and left ventricular remodeling. Clin J Am Soc Nephrol. 2013;8(12):2106-2116.

Chan CT, Greene T, Chertow GM, Kliger AS, Stokes JB, Beck GJ, Daugirdas JT, Kotanko P, Larive B, Levin NW, Mehta RL, Rocco M, Sanz J, Schiller BM, Yang PC, Rajagopalan S, Burkart J, Moossavi S, Mauck V, Kaufman T, et al. Determinants of left ventricular mass in patients on hemodialysis: Frequent Hemodialysis Network (FHN) Trials. Circ Cardiovasc Imaging. 2012;5(2):251-261.

Hall YN, Larive B, Painter P, Kaysen GA, Lindsay RM, Nissenson AR, Unruh ML, Rocco MV, Chertow GM, Burkart J, Moosavi S, Mauck V, Kaufman T, et al. Effects of six versus three times per week hemodialysis on physical performance, health, and functioning: Frequent Hemodialysis Network (FHN) randomized trials. Clin J Am Soc Nephrol. 2012;7(5):782-794.

Sergeyeva O, Gorodetskaya I, Ramos R, Schiller BM, Larive B, Raimann JG, Ting GO, Eggers PW, Chertow GM, Levin NW, Rocco M, Burkart J, Moossavi S, Mauck V, Kaufman T, Coppley A, et al. Challenges to enrollment and randomization of the Frequent Hemodialysis Network (FHN) Daily Trial. J Nephrol. 2012;25(3):302-309.

Reeves-Daniel AM, Farney A, Fletcher A, Assimos DG, Westcott CJ, Ghanta M, Stratta RJ, Rogers J, Rocco MV, Freedman BI. Race, insurance status, and living kidney donation [abstract]. Am J Transplant. 2012;12(Suppl 3):332.

Rocco MV, Kliger AS. Benefits of frequent nocturnal home hemodialysis [reply to letter]. Kidney Int. 2012;82(1):115.

Burrowes JD, Russell GB, Unruh M, Rocco MV. Is nutritional status associated with self-reported sleep quality in the HEMO study cohort?. J Ren Nutr. 2012;22(5):461-471.

Kramer H, Berns JS, Nally J, Choi MJ, Rocco MV. A decade after the KDOQI CKD guidelines: impact on NKF-KDOQI [editorial]. Am J Kidney Dis. 2012;60(5):694-696.

Rocco MV, Berns JS. KDOQI Clinical Practice Guideline for Diabetes and CKD: 2012 update. Am J Kidney Dis. 2012;60(5):850-886.

Freedman BI, Langefeld CD, Turner J, Nunez M, High KP, Spainhour M, Hicks PJ, Bowden DW, Reeves-Daniel AM, Murea M, Rocco MV, Divers J. Association of APOL1 variants with mild kidney disease in the first-degree relatives of African American patients with non-diabetic end-stage renal disease. Kidney Int. 2012;82(7):805-811.

Freedman BI, Murea M, Rocco MV, Ma L, Bowden DW, Ornelles DA, Kleiboeker S, Langefeld CD, Turner J, Divers J. JC polyoma virus interacts with apolipoprotein L1 genetic risk in African Americans with non-diabetic nephropathy [abstract]. J Am Soc Nephrol. 2012;23():178A.

Rocco MV, Larive B, Eggers PW, Beck GJ, Chertow GM, Levine NW, Kliger AS. Baseline characteristics of participants in the Frequent Hemodialysis Network (FHN) daily and nocturnal trials. Am J Kidney Dis. 2011;57(1):90-100.

Gopalakrishnan I, Iskandar SS, Daeihagh P, Divers J, Langefeld CD, Bowden DW, Hicks PJ, Rocco MV, Freedman BI. Coincident idiopathic focal segmental glomerulosclerosis collapsing variant and diabetic nephropathy in an African American homozygous for MYH9 risk variants. Hum Pathol. 2011;42(2):291-294.

Kaysen GA, Larive B, Painter P, Craig A, Lindsay RM, Rocco MV, Daugirdas JT, Schulman G, Chertow GM. Baseline physical performance, health, and functioning of participants in the Frequent Hemodialysis Network (FHN) trial. Am J Kidney Dis. 2011;57(1):101-112.

Reeves-Daniel AM, DePalma JA, Bleyer AJ, Rocco MV, Murea M, Adams PL, Langefeld CD, Bowden DW, Hicks PJ, Stratta RJ, Lin J-J, Kiger DF, Gautreaux MD, Divers J, Freedman BI. The APOL1 gene and allograft survival after kidney transplantation. Am J Transplant. 2011;11(5):1025-1030.


Leung J, Dwyer J, Hibberd P, Jacques P, Rand W, Rocco MV. Association between adherence to folic acid supplements and serum folate, and plasma homocysteine among hemodialysis patients. J Ren Nutr. 2011;21(3):246-256.

Freedman BI, Andries L, Shihabi ZK, Rocco MV, Byers JR, Cardona CY, Graham AD, Mauck VL, Russell GB, Bleyer AJ, et al. Glycated albumin and risk of death and hospitalizations in diabetic dialysis patients. Clin J Am Soc Nephrol. 2011;6(7):1635-1643.

Levin NW, Raimann JG, Rocco MV. Should the knowledge gained from the Frequent Hemodialysis Network (FHN) trials change dialysis practice?. Curr Opin Nephrol Hypertens. 2011;20(6):577-582.

Rocco MV. Hemodialysis In: Lerma EV, Nissenson AR, eds. Nephrology secrets. 3rd ed. St. Louis (MO): Elsevier Mosby;2011: 371-381.

Rocco MV, Lockridge RS Jr, Beck GJ, Eggers PW, Gassman JJ, Greene T, Burkart J, Moossavi S, Mauck V, Kaufman T, et al. The effects of frequent nocturnal home hemodialysis: the Frequent Hemodialysis Network Nocturnal Trial. Kidney Int. 2011;80(10):1080-1091.

Chan CT, Beck GJ, Chertow GM, Daugirdas JT, Greene TH, Kotanko P, Larive B, Levin NW, Mehta RL, Rocco MV, et al. Effects on ventricular volumes by frequent hemodialysis: results from the Frequent Hemodialysis Network (FHN) trials [abstract]. J Am Soc Nephrol. 2011;22(Abstract Suppl):94A.

Suri R, Larive B, Sherer SG, Gassman JJ, Ornt DB, Rocco MV, James SH, Lindsay RM, Ting GO, Eggers PW, et al. Risk of vascular access events in the FHN daily trial [abstract]. J Am Soc Nephrol. 2011;22(Abstract Suppl):108A.

Freedman BI, Langefeld CD, Murea M, Ma L, Otvos JD, Turner J, Antinozzi PA, Rocco MV, Parks JS. Apolipoprotein L1 (APOL1) nephropathy risk variants associate with HDL subfraction concentration in African Americans [abstract]. J Am Soc Nephrol. 2011;22(Abstract Suppl):178A.

Unruh ML, Larive B, Chertow GM, Eggers PW, Garg AX, Rocco M, Burkart J, Moossavi S, Mauck V, Kaufman T, et al. Effects of six versus three times per week hemodialysis on depressive affect and mental health: Frequent Hemodialysis Network (FHN) trials [abstract]. J Am Soc Nephrol. 2011;22(Abstract Suppl):255A.

Hall YN, Larive B, Painter PL, Kaysen GA, Lindsay RM, Rocco MV, Burkart J, Moossavi S, Mauck V, Kaufman T, et al. Effects of six versus three times per week hemodialysis on physical performance, health and functioning: Frequent Hemodialysis Network (FHN) trials [abstract]. J Am Soc Nephrol. 2011;22(Abstract Suppl):66A.

Freedman BI, Langefeld CD, Murea M, Ma L, Otvos JD, Turner J, Antinozzi PA, Divers J, Hicks PJ, Bowden DW, Rocco MV, Parks JS. Apolipoprotein L1 nephropathy risk variants associate with HDL subfraction concentration in African Americans. Nephrol Dial Transplant. 2011;26(11):3805-3810.

Daugirdas JT, Depner TA, Greene T, Levin NW, Chertow GM, Rocco MV. Standard Kt/Vurea: a method of calculation that includes effects of fluid removal and residual kidney clearance. Kidney Int. 2010;77(7):637-644.


Pipkin M, Eggers PW, Larive B, Rocco MV, Stokes JB, Suri RS, Lockridge RS Jr. Recruitment and training for home hemodialysis: experience and lessons from the nocturnal dialysis trial. Clin J Am Soc Nephrol. 2010;5(9):1614-1620.

Chughtai HL, Morgan TM, Rocco M, Stacey B, Brinkley TE, Ding J, Nicklas B, Hamilton C, Hundley WG. Renal sinus fat and poor blood pressure control in middle-aged and elderly individuals at risk for cardiovascular events. Hypertension. 2010;56(5):901-906.

Pierce DA, Rocco MV. Trisodium citrate: an alternative to unfractionated heparin for hemodialysis catheter dwells. Pharmacotherapy. 2010;30(11):1150-1158.

Chertow GM, Levin NW, Beck GJ, Depner TA, Eggers PW, Gassman JJ, Gorodetskaya I, Greene T, James S, Rocco MV, et al. In-center hemodialysis six times per week versus three times per week. N Engl J Med. 2010;363(24):2287-2300.

Rocco MV. Short daily and nocturnal hemodialysis: new therapies for a new century? [editorial]. Saudi J Kidney Dis Transpl. 2009;20(1):1-11.

Rocco MV, Moossavi S. Hemodialysis In: Lerma EV, Berns JS, Nissenson AR, eds. Current diagnosis & treatment: nephrology & hypertension. New York: McGraw-Hill Medical;2009: 437-443.

Hartmann EL, Kitzman D, Rocco M, Leng X, Klepin H, Gordon M, Rejeski J, Berry M, Kritchevsky S. Physical function in older candidates for renal transplantation: an impaired population. Clin J Am Soc Nephrol. 2009;4(3):588-594.

Rocco MV. Disease management programs for CKD patients: the potential and pitfalls. Am J Kidney Dis. 2009;53(3 Suppl 3):S56-S63.

Frankenfield DL, Rocco MV. Chronic disease surveillance and chronic kidney disease In: Molony DA, Craig JC, eds. Evidence-based nephrology. Oxford (UK): Wiley-Blackwell;2009: 18-28.

McClellan WM, Wasse H, McClellan AC, Kipp A, Waller LA, Rocco MV. Treatment center and geographic variability in pre-ESRD care associate with increased mortality. J Am Soc Nephrol. 2009;20(5):1078-1085.

Frankenfield DL, Krishnan SM, Ashby VB, Shearon TH, Rocco MV, Saran R. Differences in mortality among Mexican-American, Puerto Rican, and Cuban-American dialysis patients in the United States. Am J Kidney Dis. 2009;53(4):647-657.

Moore SM, Charvat JM, Andrisin S, Lissemore F, Ribisl P, Rocco M. Influence of metabolic syndrome on the adoption of lifestyle exercise following cardiac events [abstract]. Circulation. 2009;119(10):e284-e285.

Eckardt K-U, Berns JS, Rocco MV, Kasiske BL. Definition and classification of CKD: the debate should be about patient prognosis--a position statement from KDOQI and KDIGO. Am J Kidney Dis. 2009;53(6):915-920.

Vachharajani TJ, Moossavi S, Kaufman T, Rocco M. Central vein hardware: cannot live with it, cannot live without it. Semin Dial. 2009;22(5):588-589.

Rocco MV, Berns JS. KDOQI in the era of global guidelines. Am J Kidney Dis. 2009;54(5):781-787.

Chughtai HL, Morgan TM, Ding JZ, Brinkley TE, Rocco M, Hamilton CA, Hundley WG. Renal sinus fat influences the number of medications needed to regulate blood pressure in patients with hypertension [abstract]. Circulation. 2009;120(18 Suppl 2):S1017.

Pipkin M, Brett L, Stokes J, Suri R, Lockridge R, Rocco M, Eggers P. Barriers to recruitment for home hemodialysis [abstract]. J Am Soc Nephrol. 2009;20(Renal Week Online Suppl):676A.

Daugirdas JT, Depner TA, Greene T, Levin N, Chertow GM, Rocco MV. The 'standard' Kt/V inadvertently reduces the contribution of residual kidney urea clearance by an average of 25-30% [abstract]. J Am Soc Nephrol. 2009;20(Renal Week Online Suppl):471A.

Daugirdas JT, Depner TA, Greene T, Levin NW, Chertow GM, Rocco MV. A model of frequent nocturnal dialysis with reduced urea generation (G) at night significantly affects urea distribution volume, G, and Kt/V [abstract]. J Am Soc Nephrol. 2009;20(Renal Week Online Suppl):463A.

Kaysen GA, Larive B, Lindsay RM, Rocco M, Daugirdas J, Chertow GM, Eggers P. Relationship between body composition and physical performance at initiation of Frequent Hemodialysis Study (FHN) [abstract]. J Am Soc Nephrol. 2009;20(Renal Week Online Suppl):458A.

Rocco MV, Kliger A, Beck G, Lockridge R, Eggers P. Baseline results from the Frequent Hemodialysis Network Nocturnal Trial [abstract]. J Am Soc Nephrol. 2009;20(Renal Week Online Suppl):193A.

Cheung AK, Greene T, Leypoldt JK, Yan G, Allon M, Delmez J, Levey AS, Levin NW, Rocco MV, Schulman G, et al. Association between serum beta2-microglobulin level and infectious mortality in hemodialysis patients. Clin J Am Soc Nephrol. 2008;3(1):69-77.

Dember LM, Beck GJ, Allon M, Delmez JA, Dixon BS, Greenberg A, Himmelfarb J, Vazquez MA, Gassman JJ, Rocco MV, et al. Effect of clopidogrel on early failure of arteriovenous fistulas for hemodialysis: a randomized controlled trial. JAMA. 2008;299(18):2164-2171.

Wasse H, Speckman RA, Frankenfield DL, Rocco MV, McClellan WM. Predictors of central venous catheter use at the initiation of hemodialysis. Semin Dial. 2008;21(4):346-351.

Daugirdas JT, Depner TA, Greene T, Kuhlmann MK, Levin NW, Chertow GM, Rocco MV. Surface-area normalized Kt/V: a method of rescaling dialysis dose to body surface area--implications for different-size patients by gender. Semin Dial. 2008;21(5):415-421.

Daugirdas JT, Levin NW, Kotanko P, Depner TA, Kuhlmann MK, Chertow GM, Rocco MV. Comparison of proposed alternative methods for rescaling dialysis dose: resting energy expenditure, high metabolic rate organ mass, liver size, and body surface area. Semin Dial. 2008;21(5):377-384.


Unruh ML, Newman AB, Larive B, Dew MA, Miskulin DC, Greene T, Beddhu S, Rocco MV, Kusek JW, Meyer KB. The influence of age on changes in health-related quality of life over three years in a cohort undergoing hemodialysis. J Am Geriatr Soc. 2008;56(9):1608-1617.

Rocco M, Deterding E, Moossavi S, Bethea C, McBride D, Warren S, Palevsky PM, Zhang JH, O'Connor TZ, Chertow GM, et al. Intensity of renal support in critically ill patients with acute kidney injury. N Engl J Med. 2008;359(1):7-20.

Levin A, Rocco M. NKF-K/DOQI: key recommendations In: Nissenson AR, Fine RN, eds. Handbook of dialysis therapy. 4th ed. Philadelphia: Saunders;2008: 364-379.

Van Wyck D, Eckardt K-U, Uhlig K, Rocco M, Levin A. Appraisal of evidence and control of bias in the Kidney Disease Outcomes Quality Initiative guideline development process [editorial]. Clin J Am Soc Nephrol. 2007;2(1):8-10.

Van Wyck D, Eckardt K-U, Uhlig K, Rocco M, Levin A. Response to 'Influence of industry on renal guideline development' [editorial]. Clin J Am Soc Nephrol. 2007;2(1):13-14.

Levin A, Rocco M. Foreword. Am J Kidney dis. 2007;49(2 Suppl 2):S10-S11.

Wasse H, Speckman RA, Frankenfield DL, Rocco MV, McClellan WM. Predictors of delayed transition from central venous catheter use to permanent vascular access among ESRD patients. Am J Kidney Dis. 2007;49(2):276-283.

Suri RS, Garg AX, Chertow GM, Levin NW, Rocco MV, Greene T, Beck GJ, Gassman JJ, Eggers PW, Star RA, et al. Frequent hemodialysis network (FHN) randomized trials: study design. Kidney Int. 2007;71(4):349-359.

Rocco MV, Ikizler TA. Nutrition In: Daugirdas JT, Blake PG, Ing TS Handbook of dialysis. 4th ed. Philadelphia: Lippincott Williams & Wilkins;2007: 462-481.

Rocco MV. More frequent hemodialysis: back to the future?. Adv Chronic Kidney Dis. 2007;14(3):e1-e9.

Rocco M, Frankenfield D, Johnson C, Skellan D, Besarab A. Adult hemodialysis patients prescribed high dose EPO: results from CMS's ESRD Clinical Performance Measures (CPM) Project [abstract]. J Am Soc Nephrol. 2007;18(Abstracts Issue):281A.

Besarab A, Frankenfield D, Johnson C, Skellan D, Rocco M. The severely anemic adult hemodialysis patient: observations from CMS's ESRD Clinical Performance Measures (CPM) Project [abstract]. J Am Soc Nephrol. 2007;18(Abstracts Issue):281A.

Besarab A, Frankenfield D, Johnson C, Skellan D, Rocco M. Trends in anemia management in HD patients: observations from the Centers for Medicare & Medicaid (CMS) Clinical Performance Measures (CPM) Project [abstract]. J Am Soc Nephrol. 2007;18(Abstracts Issue):282A.

Wasse H, Hopson S, Soucie M, Rocco MV, Hodgin E, Pastan S, McClellan WM. Arteriovenous fistula use at hemodialysis initiation is associated with surgical performance and pre-dialysis nephrology care [abstract]. J Am Soc Nephrol. 2007;18(Abstracts Issue):464A.

Rocco M, Frankenfield D, Johnson C, Skellan D, Besarab A. Ten year analysis of adult peritoneal dialysis patients with severe anemia results from CMS's ESRD Clinical Performance Measures (CPM) Project [abstract]. J Am Soc Nephrol. 2007;18(Abstracts Issue):474A.

Rocco M, Frankenfield D, Skellan D, Besarab A, Johnson C. Ten year cross-sectional trends in anemia management in adult peritoneal dialysis patients: results from CMS's ESRD Clinical Performance Measures (CPM) Project [abstract]. J Am Soc Nephrol. 2007;18(Abstracts Issue):474A.

Rocco M, Frankenfield D, Besarab A, Skellan D, Johnson C. Ten year analysis of EPO dosing for adult peritoneal dialysis patients. Results from CMS's ESRD Clinical Performance Measures (CPM) Project [abstract]. J Am Soc Nephrol. 2007;18(Abstracts Issue):490A.

Argyropoulos C, Larive B, Miskulin D, Greene T, Beddhu S, Rocco M, Kusek J, Meyer K, Unruh M. Predictors of mortality and hospitalization among elderly hemodialysis patients over a three year period [abstract]. J Am Soc Nephrol. 2007;18(Abstracts Issue):715A.

McClellan W, Hopson S, Wasse H, Rocco M. Health at the start of hemodialysis and short term survival are associated with duration pre-dialysis nephrology care [abstract]. J Am Soc Nephrol. 2007;18(Abstracts Issue):720A.

Johnson CA, Rocco MV, Frankenfield DL, Besarab A. Analysis of intravenous (IV) iron prescribing in prevalent US hemodialysis patients: 2002-2005 data from the ESRD Clinical Performance Measures (CPM) Project [abstract]. J Am Soc Nephrol. 2007;18(Abstracts Issue):734A.

Besarab A, Frankenfield DL, Johnson CA, Skellan D, Rocco M. Anemia management of dialysis patients from 1995 to 2004: factors affecting no-erythropoietin treatment (NO-EPO) [abstract]. J Am Soc Nephrol. 2007;18(Abstracts Issue):735A.

Frankenfield DL, Besarab A, Rocco MV, Johnson CA. Comparison of subcutaneous (SC) EPO use in hemodialysis (HD) and peritoneal dialysis (PD) patients in the ESRD Clinical Performance Measures (CPM) Project [abstract]. J Am Soc Nephrol. 2007;18(Abstracts Issue):919A.

Beddhu S, Cheung AK, Larive B, Greene T, Kaysen GA, Levey AS, Rocco M, Sarnak M, Toto R, Eknoyan G. Inflammation and inverse associations of body mass index and serum creatinine with mortality in hemodialysis patients. J Ren Nutr. 2007;17(6):372-380.

Rocco MV. Revisions to KDOQI guidelines released at the NKF 2006 Spring Clinical Meetings [newsmagazine article]. Nephrol News Issues. 2006;20(8):40,42.

Rocco MV, Frankenfield DL, Hopson SD, McClellan WM. Relationship between clinical performance measures and outcomes among patients receiving long-term hemodialysis. Ann Intern Med. 2006;145(7):512-519.

Prowant B, Frankenfield D, Kinney R, Rocco M, Flanigan M. Trends in peritoneal dialysis (PD)--data from the Centers for Medicare and Medicaid Services (CMS) ESRD Clinical Performance Measures (CPM) Project [abstract]. Nephrol Nurs J. 2006;33(2):142.

Rocco M, Chen S, Frankenfield D, Daniels F, Collins A. Mortality risks in diabetic and non-diabetic hemodialysis patients. Results from the CMS ESRD Clinical Performance Measures (CPM) Project [abstract]. J Am Soc Nephrol. 2006;17(Abstr Issue):321A.

Frankenfield DL, McClellan WM, Rocco MV. Reasons for catheter use in adult hemodialysis patients in the U.S.: finding from the ESRD Clinical Performance Measures (CPM) Project [abstract]. J Am Soc Nephrol. 2006;17(Abstr Issue):318A.

Rocco M, Chen S, Frankenfield D, Daniels F, Collins A. Effect of body mass index on death and hospitalizations in diabetic and non-diabetic hemodialysis patients. Results from CMS ESRD Clinical Performance Measures (CPM) Project [abstract]. J Am Soc Nephrol. 2006;17(Abstr Issue):418A.

Levin NW, Imbasciati E, Combe C, Rocco MV, Lok CE, Donnelly SM, Dougherty FC. Adequate Hb levels are maintained with IV C.E.R.A. (Continuous Erythropoietin Receptor Activator) administered up to once monthly in dialysis patients irrespective of age, gender or diabetic status [abstract]. J Am Soc Nephrol. 2006;17(Abstr Issue):619A.

Daugirdas JT, Depner TA, Greene T, Kuhlmann MK, Chertow GR, Rocco MV. SAN (Surface Area Normalized) values for single-pool and standard Kt/V [abstract]. J Am Soc Nephrol. 2006;17(Abstr Issue):60A.

Rocco MV, Mahadevan S, Wolfe RA, Shearon TH, Ashby VB, Frankenfield DL, Saran R. No association of BMI with mortality in chronic PD patients: results from the CMS ESRD Clinical Performance Measures (CPM) Project [abstract]. J Am Soc Nephrol. 2006;17(Abstr Issue):270A.

Speckman RA, Wasse H, Rocco MV, Frankenfield DL, McClellan WM. Body mass index, vascular access and mortality among incident hemodialysis patients [abstract]. J Am Soc Nephrol. 2006;17(Abstr Issue):419A.

Wasse H, Speckman RA, Frankenfield DL, Rocco MV. AV fistula use at dialysis initiation is associated with decreased cardiovascular mortality among ESRD patients [abstract]. J Am Soc Nephrol. 2006;17(Abstr Issue):497A-498A.

Frankenfield DL, Rocco MV, McClellan WM. Disparity in vascular access for adult hemodialysis patients by Hispanic sub-groups? Findings from the ESRD Clinical Performance Measures Project [abstract]. J Am Soc Nephrol. 2006;17(Abstr Issue):315A.

Frankenfield DL, McClellan WM, Rocco MV. Reasons for catheter access in incident and prevalent hemodialysis patients [abstract]. J Am Soc Nephrol. 2006;17(Abstr Issue):315A.

Hopson SD, Frankenfield DL, Rocco MV, McClellan WM. Gender, racial and regional differences in reasons for catheter use: findings from the ESRD Clinical Performance Measures Project [abstract]. J Am Soc Nephrol. 2006;17(Abst Issue):315A.

Levin A, Rocco M. Foreword. Am J Kidney Dis. 2006;48(1 Suppl 1):S6-S7.

Levin A, Rocco M. Foreword. Am J Kidney Dis. 2006;48(1 Suppl 1):S95.

Levin A, Rocco M. Foreword. Am J Kidney Dis. 2006;48(1 Suppl 1):S183.

All Publications

For a listing of recent publications, refer to PubMed, a service provided by the National Library of Medicine.

For a list of earlier publications, visit the Carpenter Library Publication Search.

Professor, Nephrology

Clinical Specialties

Renal Failure, Nephrolithiasis, Clinical Nephrology, Dialysis, Hypertension, Nephrology, Kidney Disease
Michael V. Rocco, M.D.

Michael V. Rocco, M.D.

Professor, Nephrology
Public Health Sciences

Doctor Rating

4.6 out of 5

Michael V. Rocco, M.D.58 Ratings
1 Comments

Doctor Ratings

The overall Patient Rating score is the average of responses to the nine questions listed below. The questions are from the Press Ganey Patient Satisfaction Survey. Responses are measured on a 1 to 5 scale, where 1 represents "very poor" and 5 represents "very good."
Press Ganey Patient Satisfaction Survey

CP concern for questions/worries
4.6
CP efforts to include in decisions
4.6
CP explanations of prob/condition
4.6
CP spoke using clear language
4.7
Friendliness/courtesy of CP
4.8
Likelihood of recommending CP
4.7
Patients' confidence in CP
4.8
Time CP spent with patient
4.5
Wait time at clinic
4



Patient Comments

Comments are taken from the Care Provider section of the Press Ganey Patient Satisfaction Survey. Comments are posted exactly as they are written. Comments are added weekly. To protect patient privacy and confidentiality, patient names are not included.

3/9/2014

I am satisfied that the care provider is looking after my best interest. Personally and Professionally; Friendly and Faithfully.

Quick Reference

Request an Appointment
New Patients

336-716-WAKE
888-716-WAKE

Existing patients may contact the clinic directly.
Find a Doctor Ways to Give
USNWR 2013-2014Magnet Hospital RecognitionConsumer Choice2014 Best DoctorsJoint Commission Report

Disclaimer: The information on this website is for general informational purposes only and SHOULD NOT be relied upon as a substitute for sound professional medical advice, evaluation or care from your physician or other qualified health care provider.